| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PNAS..107.2989B |
| P356 | DOI | 10.1073/PNAS.0915148107 |
| P932 | PMC publication ID | 2840294 |
| P698 | PubMed publication ID | 20133621 |
| P5875 | ResearchGate publication ID | 41408473 |
| P50 | author | Cathrin Brisken | Q58667668 |
| Manfred Beleut | Q59192015 | ||
| Pascal Schneider | Q40058302 | ||
| P2093 | author name string | Yongwon Choi | |
| Ayyakkannu Ayyanan | |||
| Renuga Devi Rajaram | |||
| Davide Germano | |||
| Marian Caikovski | |||
| P2860 | cites work | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase | Q24295084 |
| Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse | Q24315716 | ||
| Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B | Q24556548 | ||
| Risk factors for breast cancer according to estrogen and progesterone receptor status | Q44753983 | ||
| Versatile retroviral vectors for potential use in gene therapy | Q45867146 | ||
| Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development | Q46477275 | ||
| Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor | Q46686001 | ||
| Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production | Q46892881 | ||
| Prolactin controls mammary gland development via direct and indirect mechanisms. | Q52176529 | ||
| Cyclin D1 provides a link between development and oncogenesis in the retina and breast | Q52206604 | ||
| Dissociation between steroid receptor expression and cell proliferation in the human breast. | Q52528046 | ||
| Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors | Q73496335 | ||
| Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins | Q74064200 | ||
| Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform | Q74281193 | ||
| Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland | Q77882685 | ||
| Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice | Q78693141 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 | ||
| Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway | Q28237113 | ||
| Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes | Q28504877 | ||
| Impaired mammary gland development in Cyl-1(-/-) mice during pregnancy and lactation is epithelial cell autonomous | Q28508152 | ||
| IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development | Q28508430 | ||
| The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse | Q28585870 | ||
| Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform | Q28586470 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Progesterone induction of calcitonin expression in the murine mammary gland | Q28591163 | ||
| C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development | Q28593949 | ||
| Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling | Q28594185 | ||
| Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities | Q29615568 | ||
| GROWTH OF MOUSE MAMMARY GLANDS IN VIVO AFTER MONOLAYER CULTURE. | Q33192691 | ||
| Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2 | Q34302372 | ||
| The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium | Q34392992 | ||
| 'Green mice' as a source of ubiquitous green cells. | Q34428099 | ||
| Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland | Q34479251 | ||
| Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human | Q34503355 | ||
| Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation | Q34573593 | ||
| Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands | Q35605817 | ||
| RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini | Q35641868 | ||
| A paracrine role for the epithelial progesterone receptor in mammary gland development | Q36064196 | ||
| Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography | Q36472123 | ||
| Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture | Q36578851 | ||
| Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression | Q36686536 | ||
| Transcriptional response of the murine mammary gland to acute progesterone exposure | Q37034915 | ||
| Selective segregation of DNA strands persists in long-label-retaining mammary cells during pregnancy | Q37038706 | ||
| Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene | Q37265676 | ||
| Role of denosumab in breast cancer | Q37571986 | ||
| High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein | Q41072145 | ||
| Effect of oestradiol on progesterone receptors in normal mammary glands and its relationship with lactation | Q42879422 | ||
| IGF-2 is a mediator of prolactin-induced morphogenesis in the breast | Q44247178 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2989-2994 | |
| P577 | publication date | 2010-01-28 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland | |
| P478 | volume | 107 |
| Q41859757 | A Progesterone-CXCR4 Axis Controls Mammary Progenitor Cell Fate in the Adult Gland |
| Q35029498 | A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file |
| Q36439454 | A potential role of progestin-induced laminin-5/α6-integrin signaling in the formation of side branches in the mammary gland |
| Q35659971 | Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors |
| Q33809166 | Aberrant Proliferation of Differentiating Alveolar Cells Induces Hyperplasia in Resting Mammary Glands of SV40-TAg Transgenic Mice |
| Q37643402 | Accurate Control of 17β-Estradiol Long-Term Release Increases Reliability and Reproducibility of Preclinical Animal Studies |
| Q33892734 | Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium. |
| Q34712100 | Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content |
| Q21195190 | Amphiregulin mediates progesterone-induced mammary ductal development during puberty |
| Q36928773 | Association analyses suggest the effects of RANK and RANKL on age at menarche in Chinese women. |
| Q88945987 | Attenuation of Mammary Gland Dysplasia and Feeding Difficulties in Tabby Mice by Fetal Therapy |
| Q28265584 | Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab |
| Q43624639 | Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen? |
| Q37901429 | Breast cancer stem cells and their role in resistance to endocrine therapy |
| Q37295330 | CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells |
| Q42586718 | CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany |
| Q35866374 | Changing concepts: Menopausal hormone therapy and breast cancer |
| Q38682103 | Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort |
| Q99635221 | Classical and Non-Classical Progesterone Signaling in Breast Cancers |
| Q92636699 | Clinical Impact of RANK Signalling in Ovarian Cancer |
| Q42439949 | Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. |
| Q36240642 | Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway. |
| Q37665648 | DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations |
| Q30240711 | Deciphering the divergent roles of progestogens in breast cancer |
| Q35110797 | Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2. |
| Q35205280 | Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion |
| Q37986124 | Denosumab for treatment of breast cancer bone metastases and beyond |
| Q36438839 | Developmental Insights into Breast Cancer Intratumoral Heterogeneity |
| Q26766266 | Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer |
| Q34430545 | Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line |
| Q36924384 | ER and PR signaling nodes during mammary gland development |
| Q26801713 | ERrrr…where are the progenitors? Hormone receptors and mammary cell heterogeneity |
| Q35889505 | Ectodysplasin regulates hormone-independent mammary ductal morphogenesis via NF-κB |
| Q35969254 | Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo |
| Q38341899 | Endocrine hormones and local signals during the development of the mouse mammary gland. |
| Q37198024 | Epimorphin is a novel regulator of the progesterone receptor isoform-a |
| Q33872622 | Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology. |
| Q37901428 | Estrogen and progesterone in normal mammary gland development and in cancer |
| Q26799290 | Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy |
| Q35348210 | From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer |
| Q35659426 | From the ranks of mammary progesterone mediators, RANKL takes the spotlight |
| Q33729654 | Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells |
| Q35029509 | High hopes for RANKL: will the mouse model live up to its promise? |
| Q28077637 | Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women |
| Q38226179 | Hormonal regulation of the immune microenvironment in the mammary gland |
| Q36903215 | Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium |
| Q38590446 | Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation. |
| Q37702464 | Huntingtin regulates mammary stem cell division and differentiation. |
| Q36033261 | Identification of NOG as a specific breast cancer bone metastasis-supporting gene |
| Q38562815 | Impact of progesterone on stem/progenitor cells in the human breast |
| Q47681521 | Increased breast tissue receptor activator of nuclear factor-κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women |
| Q47250561 | Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives. |
| Q34613461 | Key signaling nodes in mammary gland development and cancer: β-catenin |
| Q41550751 | Lineage-Restricted Mammary Stem Cells Sustain the Development, Homeostasis, and Regeneration of the Estrogen Receptor Positive Lineage |
| Q45988712 | Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation. |
| Q27312866 | Luminal progenitors restrict their lineage potential during mammary gland development |
| Q26740086 | Mammary Development and Breast Cancer: A Wnt Perspective |
| Q24629797 | Mammary gland development |
| Q28075791 | Mammary gland stem cells and their application in breast cancer |
| Q38233361 | Mammary stem cells: expansion and animal productivity |
| Q35825222 | Marginal maternal zinc deficiency in lactating mice reduces secretory capacity and alters milk composition |
| Q35777541 | Megestrol Acetate Increases the Proliferation, Migration, and Adipogenic Differentiation of Adipose-Derived Stem Cells via Glucocorticoid Receptor |
| Q89881398 | Membrane expression of the estrogen receptor ERα is required for intercellular communications in the mammary epithelium |
| Q33631557 | Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios? |
| Q33559178 | Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification |
| Q26997928 | Molecular determinants of context-dependent progesterone receptor action in breast cancer |
| Q90397955 | New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity |
| Q37690101 | New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells. |
| Q33456377 | Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank. |
| Q58568409 | Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium |
| Q24605866 | Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer |
| Q36273402 | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort |
| Q35838272 | Paracrine Met signaling triggers epithelial-mesenchymal transition in mammary luminal progenitors, affecting their fate |
| Q37690566 | Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity? |
| Q28508026 | Paracrine-rescued lobulogenesis in chimeric outgrowths comprising progesterone-receptor-null mammary epithelium and redirected wild-type testicular cells |
| Q33636789 | Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. |
| Q33739278 | Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland |
| Q33568421 | Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs |
| Q38669803 | Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment |
| Q35108906 | Progesterone action in breast, uterine, and ovarian cancers |
| Q34321877 | Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. |
| Q90073087 | Progesterone and Breast Cancer |
| Q26799158 | Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis |
| Q35192742 | Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk |
| Q42471079 | Progesterone induces adult mammary stem cell expansion |
| Q37151117 | Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland |
| Q33998721 | Progesterone receptor action: defining a role in breast cancer |
| Q37249108 | Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells |
| Q35113788 | Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells |
| Q35784828 | Progesterone regulation of stem and progenitor cells in normal and malignant breast |
| Q38109029 | Progesterone signalling in breast cancer: a neglected hormone coming into the limelight |
| Q51374002 | Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. |
| Q51042996 | Progesterone/RANKL is a major regulatory axis in the human breast. |
| Q21092903 | Progestin effects on cell proliferation pathways in the postmenopausal mammary gland |
| Q36473370 | Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer |
| Q38572022 | Progestogens and risk of breast cancer: a link between bone and breast? |
| Q57133933 | Proliferative heterogeneity of murine epithelial cells in the adult mammary gland |
| Q36738875 | Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression |
| Q52567969 | Psychosocial Stress Exposure Disrupts Mammary Gland Development. |
| Q37690070 | Pubertal high fat diet: effects on mammary cancer development. |
| Q36200979 | RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1. |
| Q38691526 | RANK as a therapeutic target in cancer. |
| Q39055979 | RANK expression on breast cancer cells promotes skeletal metastasis |
| Q39670403 | RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. |
| Q28294501 | RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis |
| Q47140509 | RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer. |
| Q33895612 | RANK rs1805034 T>C polymorphism is associated with susceptibility of esophageal cancer in a Chinese population |
| Q37865171 | RANKL inhibition: a promising novel strategy for breast cancer treatment. |
| Q60917149 | RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives |
| Q37725437 | RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer |
| Q42486557 | Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. |
| Q28740575 | Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients |
| Q34750367 | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit |
| Q34358320 | Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury |
| Q38373935 | Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells |
| Q37207611 | Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis |
| Q90661038 | Scribble promotes alveologenesis in the pregnant mammary gland for milk production |
| Q36246176 | Stem and progenitor cell division kinetics during postnatal mouse mammary gland development |
| Q35598825 | Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling |
| Q26849690 | Targeting RANKL in metastasis |
| Q34281611 | Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. |
| Q34468146 | Tetratricopeptide repeat domain 9A negatively regulates estrogen receptor alpha activity |
| Q41036251 | The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy |
| Q52727420 | The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors. |
| Q95643120 | The RNA binding protein CPEB2 regulates hormone sensing in mammary gland development and luminal breast cancer |
| Q26865458 | The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment |
| Q53807792 | The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer. |
| Q35868802 | The biology of progesterone receptor in the normal mammary gland and in breast cancer |
| Q36220795 | The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature |
| Q38029394 | The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction |
| Q43059366 | The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts |
| Q90621997 | The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells |
| Q35000783 | The influence of tamoxifen on normal mouse mammary gland homeostasis |
| Q34396558 | The mammary cellular hierarchy and breast cancer. |
| Q35012999 | The mammary gland microenvironment directs progenitor cell fate in vivo |
| Q26799993 | The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes |
| Q90695287 | The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche |
| Q36640852 | The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals |
| Q34388848 | Tracking progesterone receptor-mediated actions in breast cancer |
| Q27335408 | Transcriptional repressor Tbx3 is required for the hormone-sensing cell lineage in mammary epithelium |
| Q35041209 | Transcriptome analysis of the hormone-sensing cells in mammary epithelial reveals dynamic changes in early pregnancy. |
| Q26849473 | Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment? |
| Q34311270 | Wnt and mammary stem cells: hormones cannot fly wingless |
| Q36329477 | Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling |
| Q34429126 | t10,c12-CLA decreases adiposity in peripubertal mice without dose-related detrimental effects on mammary development, inflammation status, and metabolism |
Search more.